MARATTO

article · Clinica Chimica Acta

The increased sensitivity of the Xpert® Xpress assay in detecting SARS-COV-2, compared to the COBAS® assay, can be attributed to the nucleocapsid gene target

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 detection and testing
  • Advanced biosensing and bioanalysis techniques

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.cca.2024.119175

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.